Acute to subacute development of neurological deficits has been reported in patients with CMT secondary to mutations in the GJB1, MPZ, SH3TC2, SPTLC1, and FIG4 genes (19, 23–29). The gene discussed is MPZ; the disease is Charcot-Marie-Tooth disease.